Theratechnologies Inc. (TSE:TH - Get Free Report)'s stock price passed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of C$2.52 and traded as high as C$3.97. Theratechnologies shares last traded at C$3.74, with a volume of 273,150 shares changing hands.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently commented on the stock. Jones Trading raised shares of Theratechnologies from a "hold" rating to a "strong-buy" rating in a research report on Friday, April 11th. Research Capitl upgraded shares of Theratechnologies to a "strong-buy" rating in a research note on Friday, February 14th.
Check Out Our Latest Research Report on Theratechnologies
Theratechnologies Trading Down 2.5 %
The company has a debt-to-equity ratio of -293.92, a quick ratio of 0.64 and a current ratio of 1.08. The company has a market cap of C$122.52 million, a price-to-earnings ratio of -43.47, a P/E/G ratio of -8.50 and a beta of 1.73. The company's fifty day moving average is C$2.59 and its two-hundred day moving average is C$2.30.
Theratechnologies Company Profile
(
Get Free Report)
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.
Recommended Stories
Before you consider Theratechnologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Theratechnologies wasn't on the list.
While Theratechnologies currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
